Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Transcriptome sequencing to detect gene fusions in cancer.

Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N, Chinnaiyan AM.

Nature. 2009 Mar 5;458(7234):97-101. doi: 10.1038/nature07638. Epub 2009 Jan 11.

2.

Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.

Takeuchi K, Choi YL, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Takada S, Yamashita Y, Satoh Y, Okumura S, Nakagawa K, Ishikawa Y, Mano H.

Clin Cancer Res. 2008 Oct 15;14(20):6618-24. doi: 10.1158/1078-0432.CCR-08-1018.

3.

A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.

Han B, Mehra R, Dhanasekaran SM, Yu J, Menon A, Lonigro RJ, Wang X, Gong Y, Wang L, Shankar S, Laxman B, Shah RB, Varambally S, Palanisamy N, Tomlins SA, Kumar-Sinha C, Chinnaiyan AM.

Cancer Res. 2008 Sep 15;68(18):7629-37. doi: 10.1158/0008-5472.CAN-08-2014.

4.

A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells.

Li H, Wang J, Mor G, Sklar J.

Science. 2008 Sep 5;321(5894):1357-61. doi: 10.1126/science.1156725. Erratum in: Science. 2015 Oct 2;350(6256):aad3463. Science. 2015 Nov 20;350(6263):921.

5.

RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose.

Hamatani K, Eguchi H, Ito R, Mukai M, Takahashi K, Taga M, Imai K, Cologne J, Soda M, Arihiro K, Fujihara M, Abe K, Hayashi T, Nakashima M, Sekine I, Yasui W, Hayashi Y, Nakachi K.

Cancer Res. 2008 Sep 1;68(17):7176-82. doi: 10.1158/0008-5472.CAN-08-0293.

6.

Overexpression of Separase induces aneuploidy and mammary tumorigenesis.

Zhang N, Ge G, Meyer R, Sethi S, Basu D, Pradhan S, Zhao YJ, Li XN, Cai WW, El-Naggar AK, Baladandayuthapani V, Kittrell FS, Rao PH, Medina D, Pati D.

Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13033-8. doi: 10.1073/pnas.0801610105. Epub 2008 Aug 26.

7.

Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.

Choi YL, Takeuchi K, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Hamada T, Haruta H, Watanabe H, Kurashina K, Hatanaka H, Ueno T, Takada S, Yamashita Y, Sugiyama Y, Ishikawa Y, Mano H.

Cancer Res. 2008 Jul 1;68(13):4971-6. doi: 10.1158/0008-5472.CAN-07-6158.

8.

Recurrent gene fusions in prostate cancer.

Kumar-Sinha C, Tomlins SA, Chinnaiyan AM.

Nat Rev Cancer. 2008 Jul;8(7):497-511. doi: 10.1038/nrc2402. Epub 2008 Jun 19. Review.

9.

Demystified molecular pathology of NUT midline carcinomas.

French CA.

J Clin Pathol. 2010 Jun;63(6):492-6. doi: 10.1136/jcp.2007.052902. Epub 2008 Jun 13. Review.

PMID:
18552174
10.

SMAD proteins control DROSHA-mediated microRNA maturation.

Davis BN, Hilyard AC, Lagna G, Hata A.

Nature. 2008 Jul 3;454(7200):56-61. doi: 10.1038/nature07086. Epub 2008 Jun 11.

11.

TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation.

Sun C, Dobi A, Mohamed A, Li H, Thangapazham RL, Furusato B, Shaheduzzaman S, Tan SH, Vaidyanathan G, Whitman E, Hawksworth DJ, Chen Y, Nau M, Patel V, Vahey M, Gutkind JS, Sreenath T, Petrovics G, Sesterhenn IA, McLeod DG, Srivastava S.

Oncogene. 2008 Sep 11;27(40):5348-53. doi: 10.1038/onc.2008.183. Epub 2008 Jun 9.

PMID:
18542058
12.

Fat and beyond: the diverse biology of PPARgamma.

Tontonoz P, Spiegelman BM.

Annu Rev Biochem. 2008;77:289-312. doi: 10.1146/annurev.biochem.77.061307.091829. Review.

PMID:
18518822
13.

Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.

Mehra R, Tomlins SA, Yu J, Cao X, Wang L, Menon A, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM.

Cancer Res. 2008 May 15;68(10):3584-90. doi: 10.1158/0008-5472.CAN-07-6154.

14.

Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.

Hermans KG, Bressers AA, van der Korput HA, Dits NF, Jenster G, Trapman J.

Cancer Res. 2008 May 1;68(9):3094-8. doi: 10.1158/0008-5472.CAN-08-0198.

15.

EML4-ALK fusion transcript is not found in gastrointestinal and breast cancers.

Fukuyoshi Y, Inoue H, Kita Y, Utsunomiya T, Ishida T, Mori M.

Br J Cancer. 2008 May 6;98(9):1536-9. doi: 10.1038/sj.bjc.6604341. Epub 2008 Apr 15.

16.

Sixty years of follow-up of Hiroshima and Nagasaki survivors: current progress in molecular epidemiology studies.

Nakachi K, Hayashi T, Hamatani K, Eguchi H, Kusunoki Y.

Mutat Res. 2008 Jul-Aug;659(1-2):109-17. doi: 10.1016/j.mrrev.2008.02.001. Epub 2008 Feb 12. Review.

PMID:
18406659
17.

An oncogene-induced DNA damage model for cancer development.

Halazonetis TD, Gorgoulis VG, Bartek J.

Science. 2008 Mar 7;319(5868):1352-5. doi: 10.1126/science.1140735. Review.

PMID:
18323444
18.

EML4-ALK fusion lung cancer: a rare acquired event.

Perner S, Wagner PL, Demichelis F, Mehra R, Lafargue CJ, Moss BJ, Arbogast S, Soltermann A, Weder W, Giordano TJ, Beer DG, Rickman DS, Chinnaiyan AM, Moch H, Rubin MA.

Neoplasia. 2008 Mar;10(3):298-302.

19.

Role of the TMPRSS2-ERG gene fusion in prostate cancer.

Tomlins SA, Laxman B, Varambally S, Cao X, Yu J, Helgeson BE, Cao Q, Prensner JR, Rubin MA, Shah RB, Mehra R, Chinnaiyan AM.

Neoplasia. 2008 Feb;10(2):177-88.

20.

EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas.

Shinmura K, Kageyama S, Tao H, Bunai T, Suzuki M, Kamo T, Takamochi K, Suzuki K, Tanahashi M, Niwa H, Ogawa H, Sugimura H.

Lung Cancer. 2008 Aug;61(2):163-9. doi: 10.1016/j.lungcan.2007.12.013. Epub 2008 Feb 1.

PMID:
18242762
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk